Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
236,234,693
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
103,803
-
Shares change
-
+103,803
-
Total reported value, excl. options
-
$2,030,000
-
Value change
-
+$2,030,000
-
Number of buys
-
3
-
Price
-
$19.56
Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q1 2014
As of 31 Mar 2014 Akebia Therapeutics, Inc. - Common Stock (AKBA) had 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 103,803 shares of stock of the company.
Largest 3 holders included GILDER GAGNON HOWE & CO LLC, Laurion Capital Management LP, and Citadel Advisors LLC.
This table shows 3 institutional shareholders of the security as of 31 Mar 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.